InsidersTradesSigma
Track the VISEN Pharmaceuticals - B share price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the authority of HKEX. Operating in the Health Care sector, VISEN Pharmaceuticals - B has published 2 public disclosures. Market capitalisation: €2.2bn. The latest transaction was disclosed on 28 April 2026 (Sale). Among the most active insiders: LU AN-BANG. The full history is free.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
6Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,088 of 28,752 companies
10.7
score / 100
Value12
Quality9
FCF yld-20%
Earn yld-11%
EV/EBITDA·
ROE-51%
Gross mgn12%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 April 2026
Declarations2 total
108,750 sharesShareXHKGHKEX:DA20260427E00462
3,500,000 sharesShareXHKGHKEX:DA20260427E00463
2 of 2 declarations
About VISEN Pharmaceuticals - B
VISEN Pharmaceuticals - B is a company focused on developing innovative treatments in the healthcare and pharmaceutical sector. It is listed on the Hong Kong Stock Exchange (XHKG).